Image of hexagons overlapping in different sizes

BLA Post-Approval Case Studies for Oncolutic Virus, IMYGIC® (TALIMONGENE LAHERPAREPVEC)

Home / Papers and Presentations / Resource
Image with text 'Cell & Gene therapy products manufacturing, quality and regulatory considerations'

Speaker Presentation McQueen Jocelyn, Amgen Inc., 2021  
BLA Post-Approval Case Studies for Oncolutic Virus, IMYGIC® (TALIMONGENE LAHERPAREPVEC)

Related Files